Alex advises corporates, private equity houses and financial institutions on a range of complex, cross-border corporate and financing transactions.
These include mergers and acquisitions, capital raisings, joint ventures and corporate restructurings. He has acted on some of the most significant corporate transactions in the British Virgin Islands, including advising Pfizer on its US$11.6 billion acquisition of NYSE-listed Biohaven Pharmaceuticals which represents the largest ever take private of a BVI company and is a go-to lawyer in the jurisdiction for public company work with a BVI nexus. He has also advised on some of the jurisdictions most significant restructuring transactions including advising FTX in bankruptcy as part of its Chapter 11 proceedings as well as advising clients on complex debt restructurings pursuant to BVI schemes of arrangement.